MED MEDIFAST INC Common Stock
NYSE · Consumer products · Wyświetl na SEC EDGAR ↗ zamknij Paź 5, 2026 10-K/10-Q Sie 3, 2026
$11,68
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$9,2252tyg. minimum
$14,1552tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$131M
P/E (TTM)
-5.0
EPS (TTM)
$-2.32
Przychody (TTM)
$317M
Twoje odznaki
Zakres 52 tyg.
$9–$14
Ocena Analityków
HOLD
Cena Docelowa
$12
P/E
-5.0
ROE
-12.4%
Marża Zysku Netto
-8.1%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
MED Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$11.68
Kapitalizacja Rynkowa (MRQ)
$131M
P/E (TTM)
-5.0
EPS (TTM)
$-2.32
Przychody (TTM)
$317M
Stopa dywidendy
0.16%
ROE (TTM)
-12.4%
Zakres 52 tyg.
$9–$14
MED Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
O MEDIFAST INC Common Stock Przegląd firmy z Wikipedii
Medifast, Inc. (NYSE: MED) is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
Subsidiaries
The company owns five subsidiaries:
Jason Pharmaceuticals, Inc.
Take Shape for Life, Inc. (TSFL) (renamed Optavia from July 2017)
Jason Enterprises, Inc.
Jason Properties, LLC
Seven Crondall, LLC
History
William Vitale, a medical doctor, founded Medifast in 1980. He sold his products directly to other doctors, who in turn prescribed them to their patients alongside behavioural counselling techniques.
The company is publicly traded on the New York Stock Exchange (symbol: MED).
On July 17, 1995, HealthRite (predecessor of Medifast) changed its name from Vitamin Specialties Corp.
In 2000 the company pivoted to a direct-to-consumer marketing program with the help of Jason Pharmaceuticals and in 2001, the company changed its name to Medifast, Inc. In 2002, Retired Marine Colonel Bradley T. MacDonald, Chairman of the Board at the time, along with clinical specialist Dr. Wayne Scott Andersen, created Take Shape For Life as a personal Coach to the Client system and the company's “Habits of Health System.”
In October 2010, Medifast was ranked number 1 on Forbes magazine's list of "America's 100 Best Small Companies". The company was ranked 18th on the 2014 list.
Medifast was named one of Forbes's 100 Most Trustworthy Companies in America in 2016 and 2017.
In July 2017, Medifast changed the name of its subsidiary Take Shape For Life to Optavia and introduced a new line of products, Optavia Essentials, directly sold from Coaches to clients.
In October 2017, Medifast relocated its headquarters to Baltimore from Owings Mills, Maryland. The company is public with a market capitalization of $2.106 billion, as of June 2022.
In December 2023, Medifast announced a partnership with LifeMD, a provider of virtual healthcare services. Under the agreement, Medifast will use LifeMD's virtual platform to offer Medifast clients a clinically supported weight management program, including the option for prescription GLP-1 medications where clinically appropriate. In return, LifeMD will provide its patients with an independent Medifast Coach and additional lifestyle support services for weight management.
False advertising settlement
In September 2012, Medifast's subsidiary, Jason Pharmaceuticals, paid a $3.7 million USD civil penalty for false advertising. The Federal Trade Commission and United States Department of Justice said that advertisements for the "Medifast 5 & 1 Plan" low-calorie diet told consumers they could "lose up to 2-5 pounds per week", and that these weight-loss claims lacked a reasonable scientific basis, and were unsubstantiated. Under the settlement, any future claims made by the company must be backed by at least one human clinical study.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
sektorConsumer products
branżaConsumer products
pracownicy380
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$386M2016-12-31 → 2025-12-31
EPS$-1.702016-12-31 → 2025-12-31
Wolny przepływ pieniężny$1M2016-12-31 → 2025-12-31
Marża netto-8.1%2016-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | MED | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | -5.0średnia z 5 lat ≈23.6 | ≈23.6 | · | · | |
| P/S (TTM) | 0.4średnia z 5 lat ≈0.7 | ≈0.7 | 0.6 | Niedowartościowany | |
| P/B (MRQ) | 0.7średnia z 5 lat ≈5.0 | ≈5.0 | 2.2 | Niedowartościowany | |
| Cena / FCF (TTM) | 32.5średnia z 5 lat ≈31.6 | ≈31.6 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 14.9średnia z 5 lat ≈12.4 | ≈12.4 | 15.9 | Zawyżona wycena | |
| Price / Tangible Book (Cena / Wartość księgowa materialna) | 0.6średnia z 5 lat ≈5.0 | ≈5.0 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | MED | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 69.2%średnia z 5 lat ≈72.5% | ≈72.5% | 71.8% | Zgodnie z | |
| Marża Operacyjna (TTM) | -6.2%średnia z 5 lat ≈6.9% | ≈6.9% | 2.8% | Słaby | |
| Marża EBITDA (TTM) | -1.8%średnia z 5 lat ≈8.5% | ≈8.5% | 3.5% | Słaby | |
| Marża przed opodatkowaniem (TTM) | -4.4%średnia z 5 lat ≈7.4% | ≈7.4% | 0.65% | Słaby | |
| Marża Zysku Netto (TTM) | -8.1%średnia z 5 lat ≈4.9% | ≈4.9% | -1.2% | Słaby | |
| ROA (TTM) | -9.7%średnia z 5 lat ≈22.9% | ≈22.9% | 4.5% | Słaby | |
| ROE (TTM) | -12.4%średnia z 5 lat ≈43.7% | ≈43.7% | 13.5% | Słaby | |
| ROIC | -23.7%średnia z 5 lat ≈39.9% | ≈39.9% | 6.2% | Słaby |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | MED | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 4.9średnia z 5 lat ≈2.8 | ≈2.8 | 1.9 | Silna płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 3.9średnia z 5 lat ≈1.7 | ≈1.7 | 0.5 | Silna płynność |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | MED | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | -36.0%średnia z 5 lat ≈-8.9% | ≈-8.9% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | -37.7%średnia z 5 lat ≈-19.9% | ≈-19.9% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | -16.2% | · | · | · | |
| EPS YoY | -97.9%średnia z 5 lat ≈-18.7% | ≈-18.7% | · | · | |
| Net Income YoY (Zysk Netto R/R) | -97.9%średnia z 5 lat ≈-20.4% | ≈-20.4% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | -76.1% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | -76.6% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | MED | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 1.4średnia z 5 lat ≈3.2 | ≈3.2 | 1.1 | Najwyższa półka | |
| Inventory Turnover (Rotacja zapasów) | 3.5średnia z 5 lat ≈3.3 | ≈3.3 | 2.4 | Najwyższa półka | |
| Revenue / Employee (Przychody / pracownika) | ≈$1.0M | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
Stopa Dywidendy0.16%
Wskaźnik Wypłaty Dywidendy-1.0%
Zannualizowane wypłaty≈$6.60
| Data ex-dywidendy | Kwota | Waluta | Stopa zwrotu |
|---|---|---|---|
| Wrz 18, 2023 | $1,65 | USD | ≈8.2% |
| Cze 26, 2023 | $1,65 | USD | ≈7.3% |
| Mar 27, 2023 | $1,65 | USD | ≈6.6% |
| Gru 19, 2022 | $1,64 | USD | ≈5.7% |
| Wrz 19, 2022 | $1,64 | USD | ≈5.4% |
| Cze 27, 2022 | $1,64 | USD | ≈3.2% |
| Mar 28, 2022 | $1,64 | USD | ≈3.5% |
| Gru 20, 2021 | $1,42 | USD | ≈2.6% |
| Wrz 20, 2021 | $1,42 | USD | ≈2.5% |
| Cze 21, 2021 | $1,42 | USD | ≈1.9% |
| Mar 29, 2021 | $1,42 | USD | ≈2.3% |
| Gru 21, 2020 | $1,13 | USD | ≈2.3% |
| Wrz 21, 2020 | $1,13 | USD | ≈3.1% |
| Cze 29, 2020 | $1,13 | USD | ≈3.0% |
| Mar 30, 2020 | $1,13 | USD | ≈5.9% |
| Gru 26, 2019 | $1,13 | USD | ≈3.1% |
| Wrz 26, 2019 | $0,75 | USD | ≈3.0% |
| Cze 27, 2019 | $0,75 | USD | ≈2.5% |
| Mar 28, 2019 | $0,75 | USD | ≈1.9% |
| Gru 20, 2018 | $0,75 | USD | ≈1.8% |
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
54.6%
Następny raport
Lis 02, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 10, 2026 | $-0.28 | $-0.66 | 57.3% |
| 31 marca 2026 | $-0.19 | $-0.53 | 63.8% | |
| 31 grudnia 2025 | $-1.65 | $-0.83 | -99.2% | |
| 30 września 2025 | $-0.21 | $-0.39 | 46.7% | |
| 30 czerwca 2025 | $0.22 | $-0.22 | 199.0% | |
| 31 marca 2025 | $-0.11 | $-0.27 | 59.7% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $386M | $602M | $1.07B | $1.60B | $1.53B | $935M | $714M | $501M | $302M | $275M | $273M | $285M | |
| Cost of Revenue | $111M | $158M | $296M | $458M | $398M | $237M | $177M | $121M | $74M | $69M | $71M | $76M | |
| Gross Profit | $275M | $445M | $776M | $1.14B | $1.13B | $698M | $537M | $380M | $228M | $206M | $201M | $209M | |
| R&D Expense | $4M | $5M | $5M | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | |
| SG&A Expense | $289M | $442M | $649M | $956M | $911M | $564M | $446M | $311M | $188M | $179M | $173M | $179M | |
| Operating Income | $-14M | $3M | $126M | $185M | $216M | $134M | $91M | $69M | $40M | $27M | $29M | $30M | |
| Other Non-op | $3M | $-4M | $-95.0K | $-747.0K | $119.0K | $-140.0K | $29.0K | $179.0K | $136.0K | $-20.0K | $326.0K | $731.0K | |
| Pretax Income | $-6M | $4M | $129M | $184M | $216M | $134M | $92M | $71M | $40M | $27M | $30M | $32M | |
| Income Tax | $13M | $2M | $29M | $40M | $52M | $31M | $14M | $15M | $13M | $9M | $10M | $11M | |
| Net Income | $-19M | $2M | $99M | $144M | $164M | $103M | $78M | $56M | $28M | $18M | $20M | $13M | |
| EPS (Basic) | $-1.70 | $0.19 | $9.13 | $12.82 | $14.01 | $8.74 | $6.62 | $4.67 | $2.32 | $1.51 | $1.68 | $1.04 | |
| EPS (Diluted) | $-1.70 | $0.19 | $9.10 | $12.73 | $13.89 | $8.68 | $6.43 | $4.62 | $2.29 | $1.49 | $1.66 | $1.03 | |
| Shares (Basic) | 10,981,000 | 10,930,000 | 10,884,000 | 11,195,000 | 11,705,000 | 11,771,000 | 11,771,000 | 11,947,000 | 11,924,000 | 11,842,000 | 11,959,000 | 12,670,000 | |
| Shares (Diluted) | 10,981,000 | 10,963,000 | 10,921,000 | 11,276,000 | 11,813,000 | 11,850,000 | 12,117,000 | 12,079,000 | 12,088,000 | 11,947,000 | 12,071,000 | 12,778,000 | |
| EBITDA | $29.0K | $16M | $140M | $196M | $223M | $141M | $96M | $73M | $44M | $32M | $36M | · |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89M | $91M | $94M | $88M | $104M | $164M | $77M | $81M | $75M | $52M | $42M | $24M | |
| Short-term Investments | $78M | $71M | $56M | $0 | $5M | $11M | $16M | $20M | $24M | $24M | $25M | $28M | |
| Receivables | · | · | · | · | · | $584.0K | $1M | $1M | $576.0K | $1M | $2M | $2M | |
| Inventory | $20M | $42M | $55M | $119M | $180M | $53M | $49M | $39M | $19M | $18M | $13M | $16M | |
| Prepaid Expense | $9M | $10M | $11M | $16M | $16M | $6M | $6M | $5M | $4M | $4M | $3M | $3M | |
| Current Assets | $202M | $214M | $224M | $223M | $307M | $234M | $154M | $146M | $125M | $101M | $87M | $82M | |
| PP&E (Net) | $31M | $38M | $51M | $57M | $56M | $28M | $26M | $20M | $19M | $20M | $29M | $33M | |
| PP&E (Gross) | $99M | $96M | $99M | $97M | $89M | $55M | $49M | $54M | $52M | $56M | $75M | $74M | |
| Accum. Depreciation | $68M | $58M | $47M | $40M | $33M | $27M | $23M | $35M | $33M | $36M | $46M | $40M | |
| Other Non-current Assets | $8M | $10M | $15M | $12M | $6M | $3M | $353.0K | $1M | $2M | $162.0K | $205.0K | $497.0K | |
| Total Assets | $248M | $284M | $310M | $316M | $398M | $276M | $195M | $169M | $146M | $121M | $116M | $116M | |
| Accounts Payable | $38M | $56M | $86M | $135M | $163M | $108M | $76M | $60M | $37M | $24M | $23M | $22M | |
| Current Liabilities | $43M | $64M | $92M | $141M | $170M | $111M | $79M | $60M | $37M | $24M | $24M | $27M | |
| Capital Leases | $6M | $10M | $16M | $20M | $26M | $7M | $10M | · | · | · | $0 | $242.0K | |
| Deferred Tax | · | · | · | · | · | · | · | · | $208.0K | $779.0K | $4M | $5M | |
| Total Liabilities | $49M | $74M | $108M | $161M | $196M | $119M | $90M | $60M | $37M | $25M | $28M | $35M | |
| Common Stock | $11.0K | $11.0K | $11.0K | $11.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | |
| Paid-in Capital | $40M | $33M | $27M | $22M | $12M | $8M | · | $9M | $5M | $3M | $0 | $1M | |
| Retained Earnings | $158M | $177M | $175M | $140M | $190M | $154M | $169M | $131M | $104M | $93M | $89M | $79M | |
| Treasury Stock | · | · | $0 | $6M | $0 | $5M | $64M | $31M | · | · | · | $0 | |
| AOCI | $234.0K | $180.0K | $248.0K | $24.0K | $111.0K | $41.0K | $25.0K | $-173.0K | $-160.0K | $-165.0K | $-62.0K | $435.0K | |
| Stockholders' Equity | $199M | $210M | $201M | $155M | $202M | $157M | $105M | $109M | $107M | $96M | $89M | $80M | |
| Liabilities + Equity | $248M | $284M | $310M | $316M | $398M | $276M | $195M | $169M | $146M | $121M | $116M | $116M | |
| Shares Outstanding | 10,991,000 | 10,938,000 | 10,896,000 | 10,873,000 | 11,593,000 | 11,772,000 | 11,764,000 | 11,868,000 | 11,971,000 | 11,871,000 | 11,797,000 | 12,075,764 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $14M | $13M | $13M | $11M | $7M | $4M | $5M | $4M | $4M | $5M | $7M | $8M | |
| Stock-based Comp | $8M | $7M | $8M | $11M | $10M | $7M | $5M | $3M | $4M | $3M | $3M | $4M | |
| Deferred Tax | $11M | $-7M | $1M | $-924.0K | $-4M | $601.0K | $2M | $-3M | $-623.0K | $-3M | $-106.0K | $286.0K | |
| Restructuring | · | · | · | · | · | · | · | · | · | $1M | · | · | |
| Other Non-cash | $-8M | $10M | $26M | $30M | $-82M | $28M | $-4M | $155.0K | $8M | $2M | $-737.0K | · | |
| Operating Cash Flow | $7M | $24M | $148M | $195M | $95M | $145M | $84M | $61M | $43M | $25M | $29M | $26M | |
| CapEx | $6M | $7M | $6M | $17M | $34M | $6M | $10M | $5M | $3M | $3M | $3M | $7M | |
| Investing Cash Flow | $-8M | $-27M | $-61M | $-11M | $-29M | $-1M | $-6M | $-1M | $-3M | $-2M | $-189.0K | $-3M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $-219.0K | $-255.0K | · | |
| Stock Repurchased | $0 | $0 | $4M | $126M | $56M | $5M | $33M | $30M | · | · | $11M | $34M | |
| Net Stock Activity | $0 | $0 | $-4M | $-126M | $-56M | $-5M | $-33M | $-30M | · | · | $-11M | · | |
| Dividends Paid | $195.0K | $715.0K | $73M | $72M | $64M | $53M | $35M | $23M | $15M | $12M | · | · | |
| Financing Cash Flow | $-564.0K | $-2M | $-80M | $-200M | $-125M | $-57M | $-82M | $-53M | $-17M | $-13M | $-12M | $-35M | |
| Net Change in Cash | $-2M | $-4M | $7M | $-16M | $-60M | $87M | $-4M | $6M | $23M | $10M | $18M | $-12M | |
| Taxes Paid | $10M | $-2M | $34M | $37M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1M | $17M | $141M | $178M | $60M | $139M | $74M | $56M | $40M | $22M | $27M | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 71.3% | 73.8% | 72.4% | 71.3% | 73.9% | 74.7% | 75.2% | 75.8% | 75.5% | 74.9% | 73.8% | · | |
| Operating Margin | -3.7% | 0.48% | 11.8% | 11.6% | 14.2% | 14.3% | 12.8% | 13.8% | 13.1% | 9.8% | 10.5% | · | |
| Net Margin | -4.8% | 0.35% | 9.3% | 9.0% | 10.8% | 11.0% | 10.9% | 11.1% | 9.2% | 6.5% | 7.3% | · | |
| Pretax Margin | -1.5% | 0.63% | 12.0% | 11.5% | 14.2% | 14.4% | 12.9% | 14.1% | 13.4% | 9.9% | 10.9% | · | |
| EBITDA Margin | 0.01% | 2.6% | 13.0% | 12.2% | 14.6% | 15.1% | 13.4% | 14.7% | 14.5% | 11.8% | 13.1% | · | |
| ROA | -7.0% | 0.70% | 31.8% | 40.2% | 48.6% | 43.7% | 42.8% | 35.4% | 20.8% | 15.0% | 17.2% | · | |
| ROE | -9.0% | 1.0% | 50.4% | 94.0% | 82.3% | 69.2% | 72.1% | 50.5% | 27.1% | 19.3% | 23.7% | · | |
| ROIC | -23.7% | 0.76% | 48.4% | 93.0% | 81.1% | 65.4% | 73.3% | 50.1% | 25.1% | 18.4% | 21.3% | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 3.3 | 2.4 | 1.6 | 1.8 | 2.1 | 1.9 | 2.4 | 3.4 | 4.1 | 3.7 | · | |
| Quick Ratio | 3.9 | 2.5 | 1.0 | 0.6 | 0.6 | 1.6 | 1.2 | 1.7 | 2.7 | 3.2 | 2.9 | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.4 | 2.0 | 3.4 | 4.5 | 4.5 | 4.0 | 3.9 | 3.2 | 2.3 | 2.3 | 2.3 | · | |
| Inventory Turnover | 3.5 | 3.3 | 3.4 | 3.1 | 3.4 | 4.6 | 4.0 | 4.1 | 3.9 | 4.4 | 4.9 | · | |
| Receivables Turnover | · | · | · | · | · | 925.1 | 583.1 | 467.4 | 307.2 | 181.8 | 166.2 | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $18.10 | $19.21 | $18.49 | $14.26 | $17.47 | $13.36 | $8.91 | $9.19 | $9.07 | $8.09 | $7.51 | · | |
| Revenue / Share | $35.13 | $54.95 | $98.16 | $141.77 | $129.19 | $78.89 | $58.90 | $41.48 | $24.95 | $22.98 | $22.60 | · | |
| Cash Flow / Share | $0.62 | $2.23 | $13.52 | $17.26 | $8.00 | $12.25 | $6.95 | $5.03 | $3.58 | $2.12 | $2.44 | · | |
| Cash / Share | $8.13 | $8.31 | $8.67 | $8.06 | $8.99 | $13.91 | $6.54 | $6.86 | $6.27 | $4.42 | $3.56 | · | |
| Dividend / Share | $0.00 | $0.00 | $4.95 | $6.56 | $5.68 | $4.52 | $3.38 | $2.19 | $1.44 | $1.07 | $0.25 | $0.00 | |
| EPS (TTM) | $-1.70 | $0.19 | $9.10 | $12.73 | $13.89 | $8.68 | $6.43 | $4.62 | $2.29 | $1.49 | $1.66 | $1.03 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -36.0% | -43.8% | -32.9% | 4.8% | 63.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -37.7% | -26.6% | 4.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -16.2% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | -97.9% | -28.5% | -8.3% | 60.0% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | -76.1% | 1.6% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | -97.9% | -30.8% | -12.5% | 59.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | -76.6% | -1.1% | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | -67.4% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $386M | $602M | $1.07B | $1.60B | $1.53B | $935M | $714M | $501M | $302M | $275M | $273M | $285M | |
| Net Income TTM | $-19M | $2M | $99M | $144M | $164M | $103M | $78M | $56M | $28M | $18M | $20M | $13M | |
| Market Cap | $117M | $193M | $732M | $1.25B | $2.43B | $2.31B | $1.29B | $1.48B | $836M | $494M | $358M | · | |
| P/E | -6.3 | 92.7 | 7.4 | 9.1 | 15.1 | 22.6 | 17.0 | 27.1 | 30.5 | 27.9 | 18.3 | 32.6 | |
| P/S | 0.3 | 0.3 | 0.7 | 0.8 | 1.6 | 2.5 | 1.8 | 3.0 | 2.8 | 1.8 | 1.3 | · | |
| P/B | 0.6 | 0.9 | 3.6 | 8.1 | 12.0 | 14.7 | 12.3 | 13.6 | 7.7 | 5.1 | 4.0 | · | |
| P / Tangible Book | 0.6 | 0.9 | 3.6 | 8.1 | 12.0 | 14.7 | · | · | · | · | · | · | |
| P / Cash Flow | 17.1 | 7.9 | 5.0 | 6.4 | 25.7 | 15.9 | 15.3 | 24.4 | 19.3 | 19.5 | 12.2 | · | |
| P / FCF | 94.0 | 11.3 | 5.2 | 7.1 | 40.2 | 16.6 | 17.4 | 26.6 | 20.9 | 22.0 | 13.5 | · | |
| Dividend Yield | 0.17% | 0.37% | 10.0% | 5.7% | 2.6% | 2.3% | 2.8% | 1.6% | 1.8% | 2.4% | · | · | |
| Earnings Yield | -15.9% | 1.1% | 13.5% | 11.0% | 6.6% | 4.4% | 5.9% | 3.7% | 3.3% | 3.6% | 5.5% | 3.1% | |
| Payout Ratio | -1.0% | 34.2% | 73.5% | 49.9% | 38.9% | 51.7% | 45.4% | 41.5% | 55.5% | 66.7% | · | · | |
| Annual Payout | $195.0K | $715.0K | $73M | $72M | $64M | $53M | $35M | $23M | $15M | $12M | · | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $76M | $76M | $75M | $89M | $106M | $116M | $119M | $140M | $169M | $175M | $191M | $236M | $296M | $349M | $337M | $390M | |
| Cost of Revenue | $23M | $24M | $23M | $27M | $29M | $31M | $31M | $34M | $45M | $47M | $50M | $58M | $85M | $103M | $104M | $108M | |
| Gross Profit | $53M | $52M | $52M | $62M | $77M | $84M | $88M | $106M | $123M | $127M | $141M | $177M | $211M | $246M | $234M | $283M | |
| SG&A Expense | $58M | $55M | $60M | $66M | $78M | $86M | $88M | $104M | $131M | $119M | $133M | $152M | $172M | $193M | $201M | $235M | |
| Operating Income | $-4M | $-3M | $-8M | $-4M | $-1M | $-1M | $708.0K | $2M | $-8M | $8M | $9M | $26M | $39M | $54M | $33M | $48M | |
| Interest Income | $1M | $1M | · | $1M | $1M | $1M | · | $1M | $1M | $1M | · | · | · | · | · | · | |
| Other Non-op | $-11.0K | $-25.0K | $-1M | $-2.0K | $3M | $487.0K | $-2M | $-2M | $-4M | $4M | $-50.0K | $7.0K | $-51.0K | $-1.0K | $-710.0K | $-17.0K | |
| Pretax Income | $-3M | $-2M | $-6M | $-3M | $3M | $526.0K | $1M | $2M | $-11M | $12M | $10M | $27M | $39M | $53M | $32M | $48M | |
| Income Tax | $109.0K | $181.0K | $12M | $-396.0K | $395.0K | $1M | $474.0K | $449.0K | $-2M | $3M | $4M | $3M | $9M | $13M | $6M | $12M | |
| Net Income | $-3M | $-2M | $-18M | $-2M | $2M | $-772.0K | $800.0K | $1M | $-8M | $8M | $6M | $23M | $30M | $40M | $27M | $36M | |
| EPS (Basic) | $-0.28 | $-0.19 | $-1.65 | $-0.21 | $0.23 | $-0.07 | $0.08 | $0.10 | $-0.75 | $0.76 | $0.55 | $2.12 | $2.78 | $3.68 | $2.46 | $3.30 | |
| EPS (Diluted) | $-0.28 | $-0.19 | $-1.64 | $-0.21 | $0.22 | $-0.07 | $0.08 | $0.10 | $-0.75 | $0.76 | $0.54 | $2.12 | $2.77 | $3.67 | $2.45 | $3.27 | |
| Shares (Basic) | 11,135,000 | 11,006,000 | · | 10,991,000 | 10,991,000 | 10,948,000 | · | 10,937,000 | 10,937,000 | 10,909,000 | · | 10,892,000 | 10,888,000 | 10,864,000 | · | 10,964,000 | |
| Shares (Diluted) | 11,135,000 | 11,006,000 | · | 10,991,000 | 11,060,000 | 10,948,000 | · | 10,971,000 | 10,937,000 | 10,958,000 | · | 10,933,000 | 10,917,000 | 10,899,000 | · | 11,042,000 | |
| EBITDA | $-4M | $188.0K | · | $-4M | $-1M | $2M | · | $2M | $-8M | $11M | · | $26M | $39M | $56M | · | $48M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $72M | $72M | $89M | $100M | $102M | $92M | $91M | $115M | $108M | $97M | · | $113M | $147M | $124M | · | $70M | |
| Short-term Investments | $98M | $97M | $78M | $74M | $61M | $73M | $71M | $55M | $55M | $59M | · | · | · | · | · | $0 | |
| Inventory | $21M | $21M | $20M | $23M | $30M | $39M | $42M | $40M | $40M | $46M | · | $58M | $69M | $97M | · | $145M | |
| Prepaid Expense | $6M | $7M | $9M | $7M | $9M | $10M | $10M | $7M | $12M | $11M | · | $8M | $13M | $10M | · | $14M | |
| Current Assets | $202M | $203M | $202M | $208M | $206M | $214M | $214M | $225M | $224M | $220M | · | $224M | $229M | $230M | · | $230M | |
| PP&E (Net) | $28M | $30M | $31M | $33M | $35M | $36M | $38M | $39M | $40M | $51M | · | $53M | $54M | $56M | · | $58M | |
| PP&E (Gross) | · | · | $99M | · | · | · | $96M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $68M | · | · | · | $58M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $6M | $7M | $8M | $7M | $8M | $9M | $10M | $11M | $12M | $14M | · | $16M | $14M | $14M | · | $13M | |
| Total Assets | $260M | $252M | $248M | $268M | $269M | $280M | $284M | $291M | $294M | $303M | · | $320M | $319M | $322M | · | $326M | |
| Accounts Payable | $36M | $38M | $38M | $41M | $40M | $52M | $56M | $66M | $69M | $71M | · | $103M | $105M | $113M | · | $148M | |
| Current Liabilities | $42M | $42M | $43M | $47M | $46M | $61M | $64M | $72M | $75M | $77M | · | $110M | $115M | $132M | · | $154M | |
| Capital Leases | $22M | $12M | $6M | $7M | $7M | $8M | $10M | $12M | $13M | $15M | · | $17M | $18M | $19M | · | $22M | |
| Total Liabilities | $64M | $54M | $49M | $54M | $53M | $69M | $74M | $84M | $88M | $92M | · | $127M | $133M | $151M | · | $176M | |
| Common Stock | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | $11.0K | · | $11.0K | $11.0K | $11.0K | · | $11.0K | |
| Paid-in Capital | $43M | $41M | $40M | $38M | $37M | $35M | $33M | $31M | $30M | $28M | · | $24M | $22M | $19M | · | $19M | |
| Retained Earnings | $153M | $156M | $158M | $176M | $178M | $176M | $177M | $176M | $175M | $183M | · | $169M | $164M | $152M | · | $132M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | · | · | |
| AOCI | $11.0K | $33.0K | $234.0K | $220.0K | $179.0K | $239.0K | $180.0K | $349.0K | $26.0K | $22.0K | · | $141.0K | $123.0K | $33.0K | · | $391.0K | |
| Stockholders' Equity | $196M | $198M | $199M | $215M | $216M | $211M | $210M | $207M | $205M | $211M | $201M | $193M | $186M | $171M | $155M | $151M | |
| Liabilities + Equity | $260M | $252M | $248M | $268M | $269M | $280M | $284M | $291M | $294M | $303M | · | $320M | $319M | $322M | · | $326M | |
| Shares Outstanding | 11,181,000 | 11,119,000 | 10,991,000 | 10,991,000 | 10,991,000 | 10,991,000 | 10,938,000 | 10,937,000 | 10,937,000 | 10,937,000 | · | 10,892,000 | 10,889,000 | 10,887,000 | · | 10,928,000 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $2M | $2M | $2M | $910.0K | $3M | $2M | $2M | $606.0K | $2M | $2M | $2M | $3M | $3M | $606.0K | $3M | $3M | |
| Deferred Tax | · | $0 | $12M | $-648.0K | $-20.0K | $20.0K | $-8M | $106.0K | $-103.0K | $112.0K | $7M | $-6M | $0 | $800.0K | $822.0K | $-2M | |
| Other Non-cash | · | $-3M | · | · | · | $-1M | · | · | · | $-7M | · | · | · | $20M | · | · | |
| Operating Cash Flow | $2M | $260.0K | $-5M | $12M | $-3M | $3M | $-5M | $9M | $13M | $7M | $11M | $30M | $43M | $64M | $52M | $55M | |
| CapEx | $969.0K | $1M | $1M | $1M | $1M | $2M | $2M | $1M | $2M | $2M | $946.0K | $2M | $2M | $2M | $9M | $2M | |
| Investing Cash Flow | $-1M | $-17M | $-5M | $-14M | $13M | $-2M | $-19M | $-2M | $-3M | $-3M | $-11M | $-46M | $-2M | $-2M | $-9M | $-2M | |
| Stock Repurchased | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $4M | $6M | $20M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-4M | · | · | |
| Dividends Paid | $83.0K | $87.0K | $0 | $0 | $1.0K | $194.0K | $0 | $1.0K | $4.0K | $710.0K | $18M | $18M | $18M | $19M | $18M | $18M | |
| Financing Cash Flow | $-83.0K | $-901.0K | $1.0K | $0 | $-2.0K | $-563.0K | $-1.0K | $-3.0K | $-20.0K | $-1M | $-18M | $-18M | $-18M | $-26M | $-24M | $-45M | |
| Net Change in Cash | $381.0K | $-18M | $-10M | $-2M | $10M | $789.0K | $-24M | $7M | $11M | $3M | $-18M | $-35M | $24M | $36M | $18M | $9M | |
| Taxes Paid | · | $241.0K | · | · | · | $3M | · | · | · | $-100.0K | · | · | · | $-46.0K | $3M | $4M | |
| Free Cash Flow | · | $-836.0K | · | · | · | $2M | · | · | · | $5M | · | · | · | $62M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.9% | 68.1% | · | 69.5% | 72.6% | 72.8% | · | 75.4% | 73.2% | 72.9% | · | 75.2% | 71.1% | 70.6% | · | 72.5% | |
| Operating Margin | -5.7% | -4.3% | · | -4.6% | -1.0% | -1.1% | · | 1.5% | -4.7% | 4.5% | · | 10.8% | 13.1% | 15.3% | · | 12.3% | |
| Net Margin | -4.1% | -2.8% | · | -2.5% | 2.4% | -0.67% | · | 0.81% | -4.8% | 4.8% | · | 9.8% | 10.2% | 11.5% | · | 9.3% | |
| Pretax Margin | -3.9% | -2.5% | · | -3.0% | 2.7% | 0.45% | · | 1.1% | -6.3% | 6.6% | · | 11.3% | 13.2% | 15.3% | · | 12.3% | |
| EBITDA Margin | -5.7% | 0.25% | · | -4.6% | -1.0% | 1.7% | · | 1.5% | -4.7% | 6.4% | · | 10.8% | 13.1% | 16.2% | · | 12.3% | |
| ROA | -1.2% | -0.80% | · | -0.81% | 0.88% | -0.26% | · | 0.37% | -2.7% | 2.7% | · | 7.2% | 9.2% | 10.8% | · | 10.4% | |
| ROE | -1.5% | -1.0% | · | -1.1% | 1.2% | -0.37% | · | 0.56% | -4.2% | 4.4% | · | 13.5% | 19.2% | 20.7% | · | 20.8% | |
| ROIC | -2.3% | -1.8% | · | -1.6% | -0.43% | 0.88% | · | 0.73% | -2.9% | 2.7% | · | 11.5% | 16.2% | 23.5% | · | 24.2% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | 4.8 | · | 4.4 | 4.5 | 3.5 | · | 3.1 | 3.0 | 2.8 | · | 2.0 | 2.0 | 1.7 | · | 1.5 | |
| Quick Ratio | 4.1 | 4.0 | · | 3.7 | 3.5 | 2.7 | · | 2.3 | 2.2 | 2.0 | · | 1.0 | 1.3 | 0.9 | · | 0.5 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.4 | 0.4 | · | 0.5 | 0.6 | 0.6 | · | 0.7 | 0.9 | 0.9 | · | 1.1 | |
| Inventory Turnover | 0.9 | 0.8 | · | 0.9 | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.7 | · | 0.6 | 0.8 | 0.7 | · | 0.8 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $17.56 | $17.78 | · | $19.53 | $19.65 | $19.19 | · | $18.96 | $18.77 | $19.29 | · | $17.72 | $17.04 | $15.70 | · | $13.77 | |
| Revenue / Share | $6.86 | $6.91 | · | $8.13 | $9.54 | $10.57 | · | $12.78 | $15.41 | $15.95 | · | $21.57 | $27.13 | $32.02 | · | $35.36 | |
| Cash Flow / Share | · | $0.02 | · | · | · | $0.31 | · | · | · | $0.66 | · | · | · | $5.88 | · | · | |
| Cash / Share | $6.43 | $6.43 | · | $9.06 | $9.25 | $8.34 | · | $10.54 | $9.88 | $8.91 | · | $10.35 | $13.54 | $11.37 | · | $6.38 | |
| Dividend / Share | · | · | · | · | · | · | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.65 | $1.65 | $1.65 | $1.64 | $1.64 | |
| EPS (TTM) | $-2.32 | $-1.82 | · | $0.02 | $0.33 | $-0.64 | · | $0.65 | $2.67 | $6.19 | · | $11.01 | $12.16 | $12.81 | · | $13.19 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $317M | $346M | · | $430M | $480M | $543M | · | $674M | $770M | $898M | · | $1.22B | $1.37B | $1.53B | · | $1.64B | |
| Net Income TTM | $-26M | $-20M | · | $247.0K | $4M | $-7M | · | $7M | $29M | $68M | · | $120M | $133M | $142M | · | $151M | |
| Market Cap | $119M | $113M | · | $150M | $154M | $148M | · | $209M | $239M | $419M | · | $815M | $1.00B | $1.13B | · | $1.18B | |
| P/E | -4.6 | -5.6 | · | 683.5 | 42.6 | -21.1 | · | 29.4 | 8.2 | 6.2 | · | 6.8 | 7.6 | 8.1 | · | 8.2 | |
| P/S | 0.4 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.5 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | |
| P/B | 0.6 | 0.6 | · | 0.7 | 0.7 | 0.7 | · | 1.0 | 1.2 | 2.0 | · | 4.2 | 5.4 | 6.6 | · | 7.9 | |
| P / Tangible Book | 0.6 | 0.6 | · | 0.7 | 0.7 | 0.7 | · | 1.0 | 1.2 | 2.0 | · | 4.2 | 5.4 | 6.6 | · | 7.9 | |
| P / Cash Flow | · | 435.8 | · | · | · | 43.5 | · | · | · | 57.6 | · | · | · | 17.6 | · | · | |
| Dividend Yield | 0.14% | 0.08% | · | 0.13% | 0.13% | 0.13% | · | 8.9% | 15.4% | 13.0% | · | 8.9% | 7.3% | 6.6% | · | 6.0% | |
| Earnings Yield | -21.9% | -17.9% | · | 0.15% | 2.4% | -4.8% | · | 3.4% | 12.2% | 16.2% | · | 14.7% | 13.2% | 12.4% | · | 12.2% | |
| Payout Ratio | · | -4.1% | · | · | · | -25.1% | · | · | · | 8.5% | · | · | · | 47.9% | · | · | |
| Annual Payout | $170.0K | $88.0K | · | $195.0K | $196.0K | $199.0K | · | $19M | $37M | $55M | · | $73M | $73M | $74M | · | $71M |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $386M | $602M | $1.07B | $1.60B | $1.53B |
| Marża Brutto % | 71.3% | 73.8% | 72.4% | 71.3% | 73.9% |
| Marża Operacyjna % | -3.7% | 0.48% | 11.8% | 11.6% | 14.2% |
| Zysk netto | $-19M | $2M | $99M | $144M | $164M |
| Rozwodniony EPS | $-1.70 | $0.19 | $9.10 | $12.73 | $13.89 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 4.7 | 3.3 | 2.4 | 1.6 | 1.8 |
| Wskaźnik Szybkości | 3.9 | 2.5 | 1.0 | 0.6 | 0.6 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $1M | $17M | $141M | $178M | $60M |
Właściciele instytucjonalni (13F) 123 emitenci · $106.7M łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
123
Wartość posiadanych akcji
$106.7M
Nowe pozycje
26
Zamknięte pozycje
24
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 26 (-5 vs poprzedni kw.) | 24 (+7 vs poprzedni kw.) | 47 (+12 vs poprzedni kw.) | 29 (-4 vs poprzedni kw.) | -931K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $8 261 052 | 778 610 | 7,74% | Akcje |
| VANGUARD GROUP INC | $7 598 810 | 711 499 | 7,12% | Akcje |
| Steamboat Capital Partners, LLC | $7 498 076 | 706 699 | 7,03% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5 758 047 | 542 700 | 5,40% | Opcja kupna |
| TWO SIGMA INVESTMENTS, LP | $5 107 452 | 481 381 | 4,79% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $4 738 575 | 446 614 | 4,44% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4 212 128 | 396 996 | 3,95% | Akcje |
| BlackRock, Inc. | $3 920 427 | 369 503 | 3,68% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $3 855 669 | 363 394 | 3,61% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $3 383 646 | 318 911 | 3,17% | Akcje |
| MORGAN STANLEY | $3 103 524 | 292 508 | 2,91% | Akcje |
| GOLDMAN SACHS GROUP INC | $2 579 132 | 243 085 | 2,42% | Akcje |
| MARSHALL WACE, LLP | $2 563 897 | 241 649 | 2,40% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $2 508 564 | 236 434 | 2,35% | Akcje |
| CITADEL ADVISORS LLC | $2 476 374 | 233 400 | 2,32% | Opcja kupna |
| Peapod Lane Capital LLC | $2 361 531 | 222 576 | 2,21% | Akcje |
| Lido Advisors, LLC | $2 337 779 | 220 337 | 2,19% | Akcje |
| Trexquant Investment LP | $2 256 577 | 212 684 | 2,12% | Akcje |
| JANE STREET GROUP, LLC | $1 749 388 | 164 881 | 1,64% | Akcje |
| COMMONS CAPITAL, LLC | $1 590 609 | 149 916 | 1,49% | Akcje |
| Quinn Opportunity Partners LLC | $1 348 658 | 127 112 | 1,26% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $1 285 312 | 121 071 | 1,20% | Akcje |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1 242 198 | 117 078 | 1,16% | Akcje |
| RBF Capital, LLC | $1 156 490 | 109 000 | 1,08% | Akcje |
| Walleye Trading LLC | $1 145 880 | 108 000 | 1,07% | Opcja kupna |
| TWO SIGMA ADVISERS, LP | $1 098 972 | 102 900 | 1,03% | Akcje |
| JPMORGAN CHASE & CO | $989 878 | 92 512 | 0,93% | Akcje |
| D. E. Shaw & Co., Inc. | $979 780 | 92 345 | 0,92% | Akcje |
| BANK OF AMERICA CORP /DE/ | $924 323 | 87 118 | 0,87% | Akcje |
| Quantinno Capital Management LP | $880 598 | 82 997 | 0,83% | Akcje |
| Divisadero Street Capital Management, LP | $847 092 | 79 839 | 0,79% | Akcje |
| Virtus Family Office LLC | $838 827 | 79 060 | 0,79% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $806 689 | 76 031 | 0,76% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $783 846 | 73 878 | 0,73% | Akcje |
| FEDERATED HERMES, INC. | $738 509 | 69 605 | 0,69% | Akcje |
| Empowered Funds, LLC | $701 374 | 66 105 | 0,66% | Akcje |
| CITADEL ADVISORS LLC | $696 016 | 65 600 | 0,65% | Opcja sprzedaży |
| VANGUARD FIDUCIARY TRUST CO | $672 006 | 63 337 | 0,63% | Akcje |
| Atom Investors LP | $659 083 | 62 119 | 0,62% | Akcje |
| CITADEL ADVISORS LLC | $597 873 | 56 350 | 0,56% | Akcje |
| STATE STREET CORP | $555 105 | 52 319 | 0,52% | Akcje |
| GREAT LAKES ADVISORS, LLC | $547 593 | 51 611 | 0,51% | Akcje |
| UBS Group AG | $532 866 | 50 223 | 0,50% | Akcje |
| Engineers Gate Manager LP | $528 686 | 49 829 | 0,50% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $508 283 | 47 906 | 0,48% | Akcje |
| SummerHaven Investment Management, LLC | $507 529 | 47 835 | 0,48% | Akcje |
| Centiva Capital, LP | $471 424 | 44 432 | 0,44% | Akcje |
| Susquehanna Portfolio Strategies, LLC | $443 254 | 41 777 | 0,42% | Akcje |
| Jump Financial, LLC | $429 705 | 40 500 | 0,40% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $422 278 | 39 800 | 0,40% | Opcja sprzedaży |
Aktywiści i właściciele 5%+ 8 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Parsa Kiai, Steamboat Capital Partners, LLC | 21 sierpnia 2026 | 7,10% | Aneks | · | SEC |
| Steamboat Capital Partners, LLC, Parsa Kiai | 20 marca 2026 | 6,00% | Pierwotne zgłoszenie | Kampania zarządu | SEC |
| Engaged Capital Flagship Master Fund, LP, Engaged Capital Co-Invest X, LP, Engaged Capital Co-Invest X-A, LP, Engaged Capital Opportunities Fund, LP, Engaged Capital Flagship Fund, LP, Engaged Capital Flagship Fund, Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling ×5 zgłoszenia | 15 lipca 2020 | · | Pierwotne zgłoszenie | · | SEC |
| Engaged Capital Master Feeder II, LP, Engaged Capital Master Feeder I, LP, Engaged Capital I, LP, Engaged Capital I Offshore, Ltd., Engaged Capital II, LP, Engaged Capital II Offshore Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling | 3 czerwca 2016 | · | Pierwotne zgłoszenie | · | SEC |
| ModusLink Securities Corp., ModusLink Global Solutions, Inc. ×6 zgłoszenia | 19 stycznia 2016 | · | Pierwotne zgłoszenie | · | SEC |
| Engaged Capital Master Feeder I, LP, Engaged Capital Master Feeder II, LP, Engaged Capital I, LP, Engaged Capital I Offshore, Ltd., Engaged Capital II, LP, Engaged Capital II Offshore Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling ×4 zgłoszenia | 1 września 2015 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 12 grudnia 2002 | · | Pierwotne zgłoszenie | · | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 6 maja 2002 | · | Pierwotne zgłoszenie | Inwestycja pasywna | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 52 insiderów · 20 dyrektorzy generalni · 28 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Michael S Mcdevitt | Chief Executive Officer | 5 stycznia 2011 S | 340 012 | 0 | 0 | $0 |
| James P. Maloney | Chief Financial Officer | 25 marca 2026 A | 73 033 | 0 | 0 | $0 |
| Timothy G Robinson | Chief Financial Officer | 20 lutego 2020 F | 47 214 | 0 | 0 | $0 |
| Connors Brendan | Chief Financial Officer | 5 stycznia 2011 S | 91 484 | 0 | 0 | $0 |
| Mehrnaz Mona Ameli | President, OPTAVIA | 17 listopada 2017 F | 10 809 | 0 | 0 | $0 |
| Margaret Macdonald Sheetz | President & COO | 1 kwietnia 2016 S | 327 346 | 0 | 0 | $0 |
| Jonathan Barrett Mackenzie | VP, Finance & CAO | 25 marca 2026 A | 20 838 | 0 | 0 | $0 |
| Stephen Kyle Johnson | VP, Finance & CAO | 17 marca 2021 A | 665 | 0 | 0 | $0 |
| Joseph P Kelleman | Vice President of Finance | 20 lutego 2019 A | 2 355 | 0 | 0 | $0 |
| Jason L Groves | Executive VP & General Counsel | 17 lutego 2015 A | 21 697 | 0 | 0 | $0 |
| Jeanette M. Mills | Executive Vice President | 18 sierpnia 2014 S | 20 116 | 0 | 0 | $0 |
| Guy Sheetz | Executive Vice President | 5 lutego 2014 A | 410 430 | 0 | 0 | $0 |
| Dominick Vietri | Executive Vice President | 5 lutego 2014 A | 3 804 | 0 | 0 | $0 |
| Brian Lloyd | Executive Vice President | 5 lutego 2014 A | 1 865 | 0 | 0 | $0 |
| Donald Gould | Executive Vice President | 5 lutego 2014 A | 6 804 | 0 | 0 | $0 |
| Brian Kagen | Executive Vice President | 5 lutego 2014 A | 3 804 | 0 | 0 | $0 |
| Jeanne M Uphouse | Executive Vice President | 5 lutego 2014 A | 3 804 | 0 | 0 | $0 |
| Brazdley T Macdonald | Exec. Chairman of the Board | 5 stycznia 2011 S | 579 521 | 0 | 0 | $0 |
| Leo Williams | Executive Vice President | 29 listopada 2010 S | 15 000 | 0 | 0 | $0 |
| Robert J Hallock | Corporate Vice President | 18 listopada 2003 P | 1 000 | 0 | 0 | $0 |
| Daniel R Chard | Dyrektor | 29 września 2026 S | 130 609 | 1 | 2 | $-47 575 |
| Parsa Kiai | Dyrektor | 26 sierpnia 2026 P | 20 270 | 8 | 0 | $1 423 577 |
| Jeffrey Matthew Rose | Dyrektor | 26 maja 2026 A | 18 419 | 0 | 0 | $0 |
| Elizabeth A. Geary | Dyrektor | 26 maja 2026 A | 31 225 | 0 | 0 | $0 |
| Andrea B Thomas | Dyrektor | 26 maja 2026 A | 35 697 | 0 | 0 | $0 |
| Ming Xian | Dyrektor | 26 maja 2026 A | · | 0 | 0 | $0 |
| Scott Schlackman | Dyrektor | 26 maja 2026 A | 42 229 | 2 | 0 | $62 950 |
| Michael A. Hoer | Dyrektor | 25 czerwca 2025 A | 26 139 | 0 | 0 | $0 |
| Jeffrey J Brown | Dyrektor | 25 czerwca 2025 A | 38 578 | 0 | 0 | $0 |
| Kevin G Byrnes | Dyrektor | 11 listopada 2021 M | 14 922 | 0 | 0 | $0 |
| Michael C Macdonald | Dyrektor | 1 października 2020 S | 266 179 | 0 | 0 | $0 |
| Carl E Sassano | Dyrektor | 17 lipca 2020 G | 18 199 | 0 | 0 | $0 |
| Charles P Connolly | Dyrektor | 9 marca 2018 M | 41 374 | 0 | 0 | $0 |
| Welling Glenn W. | Dyrektor | 1 grudnia 2017 S | 22 380 | 0 | 0 | $0 |
| Jorgene K. Hartwig | Dyrektor | 13 marca 2017 M | 9 808 | 0 | 0 | $0 |
| Barry B Bondroff | Dyrektor | 11 czerwca 2015 S | 14 533 | 0 | 0 | $0 |
| John P Mcdaniel | Dyrektor | 4 czerwca 2015 S | 18 289 | 0 | 0 | $0 |
| Jerry D Reece | Dyrektor | 17 lutego 2015 A | 8 792 | 0 | 0 | $0 |
| Harvey C Barnum JR | Dyrektor | 17 lutego 2015 A | 8 742 | 0 | 0 | $0 |
| Catherine T Maguire | Dyrektor | 17 lutego 2015 A | 15 074 | 0 | 0 | $0 |
| Donald F Reilly | Dyrektor | 17 lutego 2015 A | 0 | 0 | 0 | $0 |
| George Lavin | Dyrektor | 31 lipca 2013 D | 24 785 | 0 | 0 | $0 |
| Joseph D Calderone | Dyrektor | 24 marca 2009 A | 21 700 | 0 | 0 | $0 |
| Carthy Dennis Mc | Dyrektor | 24 marca 2009 A | 17 075 | 0 | 0 | $0 |
| Michael J Mcdevitt | Dyrektor | 15 lutego 2007 A | 17 400 | 0 | 0 | $0 |
| VISIUM BALANCED MASTER FUND, LTD. | Posiadacz 10% | 31 maja 2016 S | 0 | 0 | 0 | $0 |
| Constance J. Hallquist | · | 6 października 2023 S | 2 152 | 0 | 0 | $0 |
| Shirley Macdonald | · | 12 maja 2010 S | 0 | 0 | 0 | $0 |
| Mary T Travis | · | 17 grudnia 2009 S | 12 583 | 0 | 0 | $0 |
| Richard J Law | · | 13 sierpnia 2009 S | 62 081 | 0 | 0 | $0 |
| RNI-NV Limited Partnership | · | 8 sierpnia 2005 S | 1 088 830 | 0 | 0 | $0 |
| Scott Zion | · | 28 lipca 2004 P | 185 000 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 18 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| VRIG · Invesco Actively Managed Exchange-T… | 0,27% | 5 000 000 | 2 października 2026 | Dziennie |
| IWC · iShares Trust | 0,03% | 36 261 SH | 11 września 2026 | Dziennie |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 16 856 SH | 19 sierpnia 2026 | Dziennie |
| DFSV · Dimensional ETF Trust | 0,01% | 60 623 NS | 31 lipca 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 2 012 NS | 31 lipca 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 37 570 NS | 31 lipca 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 5 322 SH | 2 października 2026 | Dziennie |
| DCOR · Dimensional ETF Trust | 0,00% | 2 019 NS | 31 lipca 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 2 079 NS | 31 lipca 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 5 600 NS | 31 lipca 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 115 543 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 318 980 SH | 19 sierpnia 2026 | Dziennie |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 64 351 SH | 19 sierpnia 2026 | Dziennie |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 9 806 SH | 19 sierpnia 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 3 076 SH | 19 sierpnia 2026 | Dziennie |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 42 929 SH | 19 sierpnia 2026 | Dziennie |
| VSGX · VANGUARD WORLD FUND | 0,00% | 1 003 SH | 19 sierpnia 2026 | Dziennie |
| SMLF · iShares Trust | · | 123 005 SH | 11 września 2026 | Dziennie |
MED Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 9 analityków
SPRZEDAJ
Średni cel
$12.00
+2,7%
0 0,0%
Mocne kupno
0 0,0%
Kup
4 44,4%
Trzymaj
4 44,4%
Sprzedaj
1 11,1%
Mocna sprzedaż
12-miesięczny cel cenowy
1 analityków · 2026-10-04Średnia cel $12.00 +2,7%
Niski$12.00
Średnia$12.00
Wysoki$12.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| MED | $117M | -6.3 | -36.0% | -4.8% | -9.0% | 71.3% |
| USNA | $355M | 33.5 | 8.3% | 1.2% | 2.0% | 78.3% |
| NUS | · | 3.0 | -14.3% | 10.8% | 22.0% | 69.5% |
| NATR | $378M | 20.4 | 5.7% | 4.1% | 12.0% | 72.4% |
| NAGE | $507M | 31.8 | 29.9% | 13.4% | 24.7% | 64.3% |
| UPXI | $62M | -0.2 | 58.1% | -984.3% | 9654.9% | 89.5% |
| FTLF | · | 25.8 | 26.4% | · | · | · |
| SKIN | $177M | -8.7 | -10.0% | -3.2% | -14.1% | 65.3% |
| LFVN | $78M | 15.6 | -20.1% | 2.8% | 15.2% | 77.6% |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 3, 2026